Cargando…

A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease

The aspartate‐to‐alanine aminotransferase ratio (AAR) is associated with liver fibrosis, but its predictive performance is suboptimal. We hypothesized that the association between AAR and liver disease depends on absolute transaminase levels and developed and validated a model to predict liver‐relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Åberg, Fredrik, Danford, Christopher J., Thiele, Maja, Talbäck, Mats, Rasmussen, Ditlev Nytoft, Jiang, Z. Gordon, Hammar, Niklas, Nasr, Patrik, Ekstedt, Mattias, But, Anna, Puukka, Pauli, Krag, Aleksander, Sundvall, Jouko, Erlund, Iris, Salomaa, Veikko, Stål, Per, Kechagias, Stergios, Hultcrantz, Rolf, Lai, Michelle, Afdhal, Nezam, Jula, Antti, Männistö, Satu, Lundqvist, Annamari, Perola, Markus, Färkkilä, Martti, Hagström, Hannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183175/ https://www.ncbi.nlm.nih.gov/pubmed/34141987 http://dx.doi.org/10.1002/hep4.1700

Ejemplares similares

Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population‐based cohort study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
por: Åberg, Fredrik, et al.
Publicado: (2023)

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2019)

Serum lipopolysaccharides predict advanced liver disease in the general population
por: Männistö, Ville, et al.
Publicado: (2019)

Association between arterial hypertension and liver outcomes using polygenic risk scores: a population-based study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Enhanced liver Fibrosis® test predicts liver-related outcomes in the general population
por: Saarinen, Kustaa, et al.
Publicado: (2023)

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
por: Lykiardopoulos, Byron, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
por: Shang, Ying, et al.
Publicado: (2020)

Alcoholic liver disease: A registry view on comorbidities and disease prediction
por: Grissa, Dhouha, et al.
Publicado: (2020)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Hagström, Hannes, et al.
Publicado: (2018)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021)

Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers
por: Hagström, Hannes, et al.
Publicado: (2022)

Endotoxemia Is Associated With an Increased Risk of Incident Diabetes
por: Pussinen, Pirkko J., et al.
Publicado: (2011)

Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts
por: Tikkanen, Emmi, et al.
Publicado: (2021)

The association of high-sensitivity C-reactive protein with future weight gain in adults
por: Santa-Paavola, Riina, et al.
Publicado: (2022)

Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022)

Bayesian Variable Selection in Searching for Additive and Dominant Effects in Genome-Wide Data
por: Peltola, Tomi, et al.
Publicado: (2012)

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2018)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals
por: Palmu, Joonatan, et al.
Publicado: (2022)

Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
por: Nasr, Patrik, et al.
Publicado: (2017)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

Poor health status before the COVID-19 pandemic is associated with unfavourable changes in health-related lifestyle
por: Jääskeläinen, Tuija, et al.
Publicado: (2023)

Development of non-communicable disease risk factors in Finland: projections up to 2040
por: Tolonen, Hanna, et al.
Publicado: (2022)

Bleeding events in lusutrombopag‐treated thrombocytopenic patients
por: Giannini, Edoardo Giovanni, et al.
Publicado: (2021)

The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys
por: Sundvall, Jouko, et al.
Publicado: (2011)

Effects of altered salt intake and diet on cytokines in humans: A 20‐week randomized cross‐over intervention study
por: Niiranen, Teemu, et al.
Publicado: (2022)

Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
por: Gruneau, Lina, et al.
Publicado: (2023)

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
por: Tapper, Elliot B., et al.
Publicado: (2016)

Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance
por: Sasaki, Ritsue, et al.
Publicado: (2019)

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts: Medium-Term Assessment of Outcomes and Complications
por: Ng, Pui Yung, et al.
Publicado: (2013)

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B., et al.
Publicado: (2014)

Noninvasive proteomic biomarkers for alcohol-related liver disease
por: Niu, Lili, et al.
Publicado: (2022)

Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
por: Julkunen, Heli, et al.
Publicado: (2023)

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study
por: Jousilahti, Pekka, et al.
Publicado: (2016)

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_80o5fcstv2l6ohsgaeoe4mm7u6